Neurological phenotype and synaptic function in mice lacking the Ca V1.3 α subunit of neuronal L-type voltage-dependent Ca 2+ channels

Neuroscience

Volumn 120, Issue 2, 2003, Pages 435-442

  Clark, N C ^a   Nagano, N ^a   Kuenzi, F M ^a   Jarolimek, W ^a   Huber, I ^c   Walter, D ^c   Wietzorrek, G ^c   Boyce, S ^a   Kullmann, D M ^b   Striessnig, J ^c   Seabrook, G R ^d  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Dihydropyridine; Hippocampus; Long term potentiation; Nociception; Pain; Synaptic plasticity

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; CALCIUM CHANNEL L TYPE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 2 AMINO 5 PHOSPHOPENTANOIC ACID; 2'-DEOXYADENOSINE TRIPHOSPHATE; 2-AMINO-5-PHOSPHOPENTANOIC ACID; CACNA1D PROTEIN, RAT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DEOXYADENOSINE PHOSPHATE; DEOXYADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; ISRADIPINE; VALINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; GENETIC CODE; HIPPOCAMPUS; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NOCICEPTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY; SENSORY SYSTEM; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BINDING SITE; BODY WEIGHT; C57BL MOUSE; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRINKING; DRUG EFFECT; EAR; EATING; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MALE; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; MOUSE MUTANT; NERVE CELL; OLIGONUCLEOTIDE PROBE; PAIN THRESHOLD; PHYSIOLOGY; RAT; ROTATION; SYNAPSE; TIME;

ANIMALS; BEHAVIOR, ANIMAL; BINDING SITES; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CASE-CONTROL STUDIES; DEOXYADENINE NUCLEOTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EAR; EATING; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOTOPE LABELING; ISRADIPINE; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; OLIGONUCLEOTIDE PROBES; PAIN THRESHOLD; PHENOTYPE; RATS; ROTATION; SYNAPSES; TIME FACTORS; VALINE;

EID: 0141888891     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00329-4     Document Type: Article

References (23)

1. 2+ channels in rat CA1 hippocampal pyramidal neurons. J Neurosci. 21:2001;RC175.
2. Cavus I., Teyler T. Two forms of long-term potentiation in area CA1 activate different signal transduction cascades. J Neurophysiol. 76:1996;3038-3047.
3. 2+ and sodium channels. Br J Pharmacol. 130:2000;669-677.
4. 2+ channels. Neuron. 25:2000;533-535.
5. Fitzjohn S.M., Morton R.A., Kuenzi F., Rosahl T.W., Shearman M., Lewis H., Smith D., Reynolds D.S., Davies C.H., Collingridge G.L., Seabrook G.R. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci. 21:2001;4691-4698.
6. 2+ channels. Methods Enzymol. 109:1985;513-550.
7. Grover L.M., Teyler T.J. Two components of long-term potentiation induced by different patterns of afferent activation. Nature. 347:1990;477-479.
8. 2+ channel alpha 1 subunits. J Cell Biol. 123:1993;949-962.
9. 2+ channel subunit mRNA expression in the hippocampus of aged F344 rats. Neurobiol Aging. 19:1998;581-587.
10. 2+ channel. Neuron. 7:1991;35-44.
11. Liu X., Rusch N.J., Striessnig J., Sarna S.K. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology. 120:2001;480-489.
12. Ludwig A., Flockerzi V., Hofmann F. Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J Neurosci. 17:1997;1339-1349.
13. Madison D.V., Nicoll R.A. Control of the repetitive discharge of rat CA1 pyramidal neurones in vitro. J Physiol. 354:1984;319-331.
14. Max M. Is mechanism-based pain treatment attainable? clinical trial issues. Pain. 1:2000;2-9.
15. 2+ channel alpha1D subunit in postnatal pancreatic β cell generation. J Clin Invest. 108:2001;1015-1022.
16. Petersen K.L., Rowbotham M.C. Will ion-channel blockers be useful for management of nonneuropathic pain? Pain. 1:2000;26-34.
17. Platzer J., Engel J., Schrott-Fischer A., Stephan K., Bova S., Chen H., Zheng H., Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ currents. Cell. 102:2000;89-92.
18. Sirinathsinghji D.J., Rigby M., Heavens R.P., Smith D., Fernandez J.M., Schuligoi R., Hill R.G. Increased messenger RNA expression of the 695 and 751 amino acid isoforms of the beta-amyloid protein precursor in the thalamus of 17-year-old cynomolgus (Macaca fascicularis) monkeys. Neuroscience. 65:1995;51-57.
19. 2+ channel activity in aged hippocampal neurons relationship to impaired synaptic plasticity . J Neurosci. 15:(21):2001;9744-9756.
20. 2+ channel subtype. Neuron. 8:1992;71-84.
21. Wyatt C.N., Campbell V., Brodbeck J., Brice N.L., Page K.M., Berrow N.S., Brickley K., Terracciano C.M., Naqvi R.U., MacLeod K.T., Dolphin A.C. Voltage-dependent binding and calcium channel current inhibition by an anti-alpha 1D subunit antibody in rat dorsal root ganglion neurones and guinea-pig myocytes. J Physiol. 502:1997;307-319.
22. Zhang Z., Xu Y., Song H., Rodriguez J., Tuteja D., Namkung Y., Shin H.S. Functional Roles of Ca(v)1.3 alpha(1D) calcium channel in sinoatrial nodes insight gained using gene-targeted Null mutant mice . Circ Res. 90:2002;981-987.
23. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.